Exelixis
EXEL
#1695
Rank
NZ$17.32 B
Marketcap
$60.66
Share price
1.92%
Change (1 day)
58.44%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company